Evaluation of Lipid Poor Renal Masses with Magnetic Resonance Spectroscopy in Tuberous Sclerosis Complex
Abstract
The Research Project supported by this DOD Award investigates the potential of in vivo and ex vivo MRS in characterizing the metabolomic spectra of TSC-associated renal masses. In an effort to optimize our in vivo image acquisition protocol, we began by scanning healthy volunteers and have formalized our novel in vivo MRS protocol, which will be submitted for publication. Subsequently, our overall enrollment of TSC patients with lipid poor renal masses had been lower than expected. For this reason and in order to meet our goals of gaining more metabolomic data on renal masses, we expanded our subjects to include TSC patients with lipid rich masses, non-TSC patients with lipid poor and lipid rich renal masses. We continue to enroll patients and analyze our current and ongoing data. Our analysis cohort was also expanded with the utilization of our MGH Genitourinary Oncology Tumor Bank, including AML and other renal tumor tissue. Our ex vivo work from the tumor bank was presented virtually at the 2020 American Urological Association national meeting and was awarded Best Poster. The manuscript is currently under preparation. The findings from this study will help the TSC community gain an understanding of the metabolomics of AML and other renal tumors.
Document Details
- Document Type
- Technical Report
- Publication Date
- Sep 01, 2020
- Accession Number
- AD1126835
Entities
People
- Adam S. Feldman
Organizations
- Massachusetts General Hospital